GlaxoSmithKline

NYSE: GSK
$40.94
+$0.15 (+0.4%)
Closing price August 10, 2020
Tesaro shares absolutely exploded early on Monday after the company announced that it has entered a definitive agreement to be acquired by GlaxoSmithKline.
Here 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and U.S. Food and Drug Administration (FDA) updates in September.
The top analyst upgrades, downgrades and initiations seen on Thursday include Glaukos, Honeywell, Itau, MongoDB, 3M, PayPal, Salesforce.com, Tandem Diabetes Care, Vodafone and National Bank of Greece.
The top analyst upgrades, downgrades and initiations seen on Monday include Applied Materials, Baker Hughes, Bloom Energy, Constellation Brands, Deere, JC Penney, Kroger, Nike and Tesla.
With bond yields still very low, dividend-yielding total return stocks may be the way to play the rest of 2018. These five stocks are ideal for investors who want to own ones that they can put in...
The top analyst upgrades, downgrades and other research calls from Thursday include Dolby Laboratories, Facebook, Freeport-McMoRan, Gilead, GrubHub and Skechers.
Here 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and FDA updates in July.
OSI Systems, Edison International, Cemex, and GlaxoSmithKline all posted new 52-week lows Wednesday.
The top analyst upgrades, downgrades and other research calls from Monday include AECOM, Ciena, Evoqua Water Tech, Funko, GlaxoSmithKline and Square.
The top analyst upgrades, downgrades and other research calls from Thursday include Barrick Gold, Buffalo Wild Wings, Caterpillar, Coca-Cola, GrubHub, Nabors Industries and Wynn Resorts.
The top analyst upgrades, downgrades and other research calls from Wednesday include Blackstone, Ciena, Merck, Tempur Sealy and Universal Display.
The top analyst upgrades, downgrades and other research calls from Friday include Analog Devices, Camping World, Ciena, Deere, RSP Permian, Ulta Beauty and Yum China.
If Warren Buffett is considered the greatest investor of the modern era, and if he has held the title of the world's richest man, then maybe he knows a thing or two.
With prescription drug spending breaking new records almost every year now, people like to blame Big Pharma and use it as the industry punching bag.
Wednesday’s top analyst upgrades, downgrades and initiations included AstraZeneca, Hasbro, Roche, Peabody Energy, Suncor and Wynn Resorts,